Impact of removing ESBL designation from culture reports on the selection of antibiotics for the treatment of infections associated with ESBL-producing organisms.

Lesher, Mark D; Hale, Cory M; Wijetunge, Dona S S; England, Matt R; Myers, Debra S; Craft, David W

Lesher, Mark D; Hale, Cory M; Wijetunge, Dona S S; England, Matt R; Myers, Debra S; Craft, David W.

Afiliação

Lesher MD; Department of Pharmacy, Milton S. Hershey Medical Center, Hershey, Pennsylvania.
Hale CM; Department of Pharmacy, Milton S. Hershey Medical Center, Hershey, Pennsylvania.
Wijetunge DSS; Pathology and Laboratory Medicine, Milton S. Hershey Medical Center, Hershey, Pennsylvania.
England MR; Pathology and Laboratory Medicine, Milton S. Hershey Medical Center, Hershey, Pennsylvania.
Myers DS; Pathology and Laboratory Medicine, Milton S. Hershey Medical Center, Hershey, Pennsylvania.
Craft DW; Pathology and Laboratory Medicine, Milton S. Hershey Medical Center, Hershey, Pennsylvania.

Infect Control Hosp Epidemiol ; 41(5): 604-607, 2020 05.

Article em En | MEDLINE | ID: mdl-32248863

Assuntos

Antibacterianos/uso terapêutico; Carbapenêmicos/uso terapêutico; Uso de Medicamentos/estatística & dados numéricos; beta-Lactamas/classificação; beta-Lactamas/uso terapêutico; Centros Médicos Acadêmicos; Enterobacteriaceae; Infecções por Enterobacteriaceae/tratamento farmacológico; Humanos; Philadelphia; Estudos Retrospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carbapenêmicos / Beta-Lactamas / Uso de Medicamentos / Antibacterianos Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google